Loss of long-term non-progressor and HIV controller status over time in the French Hospital Database on HIV - ANRS CO4

Abstract

ObjectivesWe studied the frequency and risk factors for loss of long-term non-progressor (LTNP) and HIV controller (HIC) status among patients identified as such in 2005 in the French Hospital Database on HIV (FHDH-ANRS CO4).MethodsWe selected patients who were treatment-naïve and asymptomatic in 2005 (baseline). Those with ≥8 years of known HIV infection and a CD4 cell nadir ≥500/mm3 were classified as LTNP and those with ≥10 years of known HIV infection and 90% of plasma viral load (VL) values ≤500 copies/ml in the absence of cART as HIC. cART initiation without loss of status and death from non AIDS-defining causes were considered as competing events.ResultsAfter 5 years of follow-up, 33% (95%CI; 27–42) of 171 LTNP patients and 17% (95%CI; 10–30) of 72 HIC patients had lost their status. In multivariable analyses, loss of LTNP status was associated with lower baseline CD4 cell counts and CD4/CD8 ratios. Only VL was significantly associated with loss of HIC status after adjustment for the baseline CD4 cell count, the CD4/CD8 ratio, and concomitant LTNP status. The hazard ratio for loss of HIC status was 5.5 (95%CI, 1.5–20.1) for baseline VL 50–500 vs ≤50 cp/mL, after adjustment for the baseline CD4 cell count.ConclusionsOne-third of LTNP and one-fifth of HIC patients lost their status after 5 years of follow-up, raising questions as to the possible benefits and timing of ART initiation in these populations.

HIV control: Is getting there the same as staying there?

“…In one multinational observational study of individuals followed from seroconversion (CASCADE), virus control (<500 copies RNA/mL) occurred in a small minority (1.4%) but once achieved was maintained in most (the probability of maintaining control over 20 years was 0.74) [ 11 ]. In a multicenter study of controllers (Collaboration of Observational HIV Epidemiological Research Europe [COHERE]), progression was rare and was predicted by a low CD4/CD8 ratio and intermittent viremia [ 67 ]; similar findings were noted in a French study [ 68 ]. In smaller pathogenesis-oriented studies, heightened inflammation and T-cell activation predated and often predicted virologic progression [ 17 , 69 , 70 ].…”

“…Virologic rebound or progression among elite controllers is uncommon [ 11 , 65 – 68 ] and poorly understood. In one multinational observational study of individuals followed from seroconversion (CASCADE), virus control (<500 copies RNA/mL) occurred in a small minority (1.4%) but once achieved was maintained in most (the probability of maintaining control over 20 years was 0.74) [ 11 ].…”

Elevated Expression of miR-19b Enhances CD8+ T Cell Function by Targeting PTEN in HIV Infected Long Term Non-progressors With Sustained Viral Suppression

“…However, viral control differs among LTNPs and the reason for this difference is currently unknown. LTNPs maintaining high viral loads are prone to long-term disease progression, with reduced life expectancy compared to HIV negative individuals (14, 15). Analysis of the underlying reason for the differing levels of viral control in LTNPs may facilitate an understanding of HIV pathogenesis and may provide for new approaches to immune intervention.…”

Therapeutic Targeting of HIV Reservoirs: How to Give T Cells a New Direction

“…Individuals who spontaneously control HIV have smaller latent reservoirs and display functionally superior CD8+ T cell responses, providing a model for functional cure (37, 38). However, loss of controller/non-progressor status is frequent, possibly due to ongoing viral replication in tissue sites that are inaccessible to cytolytic T cells (39–41).…”